Ischemic colitis (IC) is an uncommon adverse event associated with antipsychotic agents, more commonly found with phenothiazine drugs and atypical neuroleptics such as clozapine.
INTRODUCTION
Ischemic colitis (IC) is the most common cause of intestinal ischemia, and represents around 50% of cases. It results from transient vascular flow deprivation in the colon (1, 2) . Most cases resolve spontaneously, but others progress to more severe presentations that require surgical management (2). Incidence rates vary with age, and oscillate from 1.1 per 100,000 inhabitant-years among patients younger than 40 years to 107 per 100,000 inhabitant-years among those at or above 80 years of age. It typically involves elderly patients with multiple comorbidities, and is associated with high in-hospital mortality (11.5%) and surgery (17%) rates (3). In clinical practice many cases are overlooked because of mild or transient presentations with no clear trigger.
Several drugs have been associated with the development of intestinal ischemia, including digitalis, diuretics, estrogens, antibiotics, and non-steroidal anti-inflammatory drugs (4) . IC is an uncommon adverse event of antipsychotic drugs, particularly phenothiazines and atypical or second-generation compounds (5) . The effect of these drugs is enhanced when anticholinergics are associated. Clozapine is the atypical antipsychotic most commonly described in the literature as a cause of IC (6) . In contrast, the IC risk associated with quetiapine is lower given its milder anticholinergic potential (7).
CASE REPORT
We report the case of a 38-year-old woman with a history of schizoaffective disorder on quetiapine (Seroquel®) (300 mg/day) for 3 years who presented to the emergency room with diarrhea (4-5 liquid stools for 5 days, without abnormal components). Four months previously another atypical antipsychotic agent, olanzapine (Zyprexa®) (20 mg/day), had been added to her regimen for improved symptom control. Physical examination was notable for: fever at 38.5°C, fast heart rate at 116 beats per minute, and blood pressure at 120/74 mmHg. Her abdomen exhibited distension with marked tympanism and highly reduced peristaltism, had tenderness in the lower third, and no masses or visceromegalies could be discerned.
Emergency labs were notable for leukocytosis at 12,000 cells/mm 3 , hemoglobin at 11.2 g/dl, C-reactive protein (CRP) at 249.1 mg/dl, erythrocyte sedimentation rate (ESR) at 89 mm/h, and fibrinogen at 876 mg/dl. Blood culture, urine culture, fecal parasites and coproculture were tested, as well as Clostridium difficile toxin. All results were negative.
Computerized tomography (CT) revealed a smooth, diffuse, concentric dilation and thickening of the colonic wall with extensive transverse, descending and sigmoid colon involvement (Fig. 1) . Suspicion of inflammatory/infectious colitis prompted colonoscopy, which confirmed the colonic segmentary involvement from the sigma to the hepatic flexure in the form of ulcerations and fibrinoid exudates ( Currently there is no clear evidence that lower antipsychotic doses may reduce gastrointestinal adverse effects. Therefore, close monitoring and patient education on the potential side effects of this medication is crucial. To prevent the constipation associated with these drugs a high-fiber diet may be recommended, as well as abundant fluid intake and physical activity to minimize the anticholinergic effects of antipsychotic medications (11) . Furthermore, the association of other psychoactive drugs with anticholinergic properties should be avoided.
To conclude, it is important that antipsychotic drugs, particularly atypical neuroleptics such as clozapine and olanzapine, are considered as a potential cause of IC, as this adverse effect, although uncommon, may result in high morbidity and mortality.
